Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute Study

BACKGROUND: Patients with early stage breast cancer with same treatment strategy can have markedly different outcomes. Human epidermal growth factor receptor 2 (HER2/nue) gene amplification or the subsequent overexpression of protein has been proved to be associated with patient's outcome and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirtavoos Mahyari, Hanifeh, Khosravi, Adnan, Mirtavoos Mahyari, Zeinab, Esfahani Monfared, Zahra, Khosravi, Negin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329964/
https://www.ncbi.nlm.nih.gov/pubmed/25763209
http://dx.doi.org/10.5812/ircmj.16005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329964/
https://www.ncbi.nlm.nih.gov/pubmed/25763209
http://dx.doi.org/10.5812/ircmj.16005

Ejemplares similares